Holen Sie sich die Stockscreener-App
22.05
3.54%
-0.81
Vorhandelsmarkt:
22.00
-0.05
-0.23%
Schlusskurs vom Vortag:
$22.86
Offen:
$22.9
24-Stunden-Volumen:
5.17M
Relative Volume:
0.74
Marktkapitalisierung:
$10.95B
Einnahmen:
$4.45B
Nettoeinkommen (Verlust:
$205.00M
KGV:
55.12
EPS:
0.4
Netto-Cashflow:
$372.00M
1W Leistung:
+2.08%
1M Leistung:
+11.59%
6M Leistung:
+72.00%
1J Leistung:
+56.16%
1-Tages-Spanne:
$22.01
$23.09
1-Wochen-Bereich:
$20.83
$23.09
52-Wochen-Spanne:
$8.02
$23.09
Elanco Animal Health Inc Stock (ELAN) Company Profile
Firmenname
Elanco Animal Health Inc
Sektor
Telefon
877-352-6261
Adresse
450 ELANCO CIRCLE, INDIANAPOLIS
Vergleichen Sie ELAN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ELAN
Elanco Animal Health Inc
|
22.05 | 11.07B | 4.45B | 205.00M | 372.00M | 0.40 |
|
ZTS
Zoetis Inc
|
121.25 | 52.79B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.09 | 43.31B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.88 | 42.61B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
25.83 | 27.83B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
461.54 | 19.54B | 3.08B | 1.24B | 1.07B | 25.61 |
Elanco Animal Health Inc Stock (ELAN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-07 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2025-07-17 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2025-06-26 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2024-12-09 | Eingeleitet | UBS | Buy |
| 2024-12-02 | Eingeleitet | Leerink Partners | Market Perform |
| 2024-09-19 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2024-01-05 | Hochstufung | Stifel | Hold → Buy |
| 2023-12-19 | Eingeleitet | Jefferies | Buy |
| 2023-12-15 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2023-12-07 | Eingeleitet | Exane BNP Paribas | Outperform |
| 2023-04-20 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2022-08-18 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-08-16 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-07-21 | Herabstufung | Goldman | Buy → Sell |
| 2022-07-12 | Eingeleitet | Piper Sandler | Neutral |
| 2021-11-18 | Eingeleitet | Morgan Stanley | Overweight |
| 2021-10-28 | Herabstufung | Stifel | Buy → Hold |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-06-15 | Hochstufung | Cleveland Research | Underperform → Neutral |
| 2021-05-11 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2021-05-11 | Hochstufung | Gabelli & Co | Hold → Buy |
| 2021-04-15 | Eingeleitet | Stifel | Buy |
| 2021-03-22 | Herabstufung | Gabelli & Co | Buy → Hold |
| 2021-02-26 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2020-12-09 | Herabstufung | Argus | Buy → Hold |
| 2020-11-09 | Herabstufung | Barclays | Overweight → Underweight |
| 2020-08-20 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2020-08-13 | Fortgesetzt | Credit Suisse | Neutral |
| 2020-08-04 | Fortgesetzt | Goldman | Buy |
| 2020-07-27 | Herabstufung | Cleveland Research | Neutral → Underperform |
| 2020-04-02 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2020-01-10 | Eingeleitet | Raymond James | Mkt Perform |
| 2019-12-19 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2019-11-07 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2019-09-23 | Eingeleitet | Barclays | Overweight |
| 2019-08-26 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2019-08-15 | Hochstufung | UBS | Sell → Neutral |
| 2019-05-23 | Eingeleitet | Guggenheim | Neutral |
| 2019-03-18 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2019-03-13 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2019-02-12 | Eingeleitet | William Blair | Mkt Perform |
| 2019-01-23 | Eingeleitet | UBS | Sell |
| 2019-01-15 | Eingeleitet | Argus | Buy |
| 2018-10-15 | Eingeleitet | Morgan Stanley | Equal-Weight |
Alle ansehen
Elanco Animal Health Inc Aktie (ELAN) Neueste Nachrichten
Elanco (NYSE: ELAN) teams with Alloy to launch OneHealth Studio for One Health innovation - Stock Titan
Elanco Animal Health Incorporated stock prediction for this weekWall Street Watch & Expert Curated Trade Setups - newser.com
Can Elanco Animal Health Incorporated (5EA) stock double in coming years2025 Biggest Moves & AI Powered Buy/Sell Recommendations - newser.com
Will Elanco Animal Health Incorporated (5EA) stock hit Wall Street targetsTrend Reversal & Reliable Entry Point Trade Alerts - newser.com
Is Elanco Animal Health Incorporated stock a buy during volatile marketsWeekly Risk Summary & Precise Swing Trade Alerts - newser.com
What to expect from Elanco Animal Health Incorporated in the next 30 daysJuly 2025 Sentiment & Verified Momentum Watchlists - newser.com
Is Elanco Animal Health Incorporated stock attractive for retirement portfoliosPortfolio Growth Summary & Daily Technical Stock Forecast Reports - newser.com
How to integrate Elanco Animal Health Incorporated into portfolio analysis toolsWall Street Watch & Stock Portfolio Risk Control - newser.com
Will Elanco Animal Health Incorporated stock beat international competitionForecast Cut & Precise Buy Zone Identification - newser.com
Will Elanco Animal Health Incorporated stock deliver shareholder valueJuly 2025 Fed Impact & Community Consensus Picks - newser.com
Best data tools to analyze Elanco Animal Health Incorporated stockDip Buying & Short-Term Trading Alerts - newser.com
Will Elanco Animal Health Incorporated (5EA) stock outperform benchmarksJuly 2025 Recap & Pattern Based Trade Signal System - newser.com
Earnings Troubles May Signal Larger Issues for Elanco Animal Health (NYSE:ELAN) Shareholders - Yahoo Finance
Will Elanco Animal Health Incorporated (5EA) stock benefit from mergersSell Signal & AI Enhanced Trade Execution Alerts - newser.com
5 Revealing Analyst Questions From Elanco’s Q3 Earnings Call - TradingView
Elanco Animal Health Incorporated’s volatility index tracking explainedJuly 2025 Earnings & Reliable Momentum Entry Alerts - newser.com
Is Elanco Animal Health Incorporated (5EA) stock a buy on weaknessWeekly Profit Recap & Verified Momentum Stock Watchlist - newser.com
Merck, Elanco, Myriad Genetics, Neogen, and Cigna Shares Are Soaring, What You Need To Know - Barchart.com
Elanco Animal Health stock hits 52-week high at 22.98 USD - Investing.com Canada
Are Options Traders Betting on a Big Move in Elanco Animal Health Stock? - TradingView
Will Elanco Animal Health Incorporated stock recover faster than marketTake Profit & Fast Momentum Entry Tips - newser.com
Will Elanco Animal Health Incorporated (5EA) stock boost dividends furtherQuarterly Earnings Report & Fast Exit and Entry Trade Guides - newser.com
Why institutional investors increase stakes in Elanco Animal Health Incorporated stockM&A Rumor & Community Trade Idea Sharing Platform - newser.com
Is Elanco Animal Health Incorporated stock bottoming out2025 Year in Review & Fast Gain Stock Trading Tips - newser.com
Risk vs reward if holding onto Elanco Animal Health IncorporatedStock Surge & Free Safe Entry Trade Signal Reports - newser.com
Finanzdaten der Elanco Animal Health Inc-Aktie (ELAN)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.29%
1.70%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):